Raymond James & Associates Phibro Animal Health Corp Transaction History

Raymond James & Associates

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$17.89 - $20.47 $19,267 - $22,046	1,077 Added 1.4%	78,152 $1.5 Million
Q1 2022 May 11, 2022	BUY	$18.39 - $21.85 $96,988 - $115,236	5,274 Added 7.35%	77,075 $1.54 Million
Q4 2021 Feb 08, 2022	SELL	$18.96 - $22.76 $119,656 - $143,638	-6,311 Reduced 8.08%	71,801 $1.47 Million
Q3 2021 Nov 02, 2021	SELL	$20.59 - $30.01 $16,245 - $23,677	-789 Reduced 1.0%	78,112 $1.68 Million
Q2 2021 Aug 11, 2021	SELL	$24.15 - $30.08 $39,992 - $49,812	-1,656 Reduced 2.06%	78,901 $2.28 Million
Q1 2021 May 14, 2021	BUY	$19.71 - $25.23 $42,672 - $54,622	2,165 Added 2.76%	80,557 $1.97 Million
Q4 2020 Feb 12, 2021	SELL	$16.44 - $20.2 $1.74 Million - $2.13 Million	-105,597 Reduced 57.39%	78,392 $1.52 Million
Q3 2020 Nov 04, 2020	SELL	$17.36 - $26.36 $157,837 - $239,665	-9,092 Reduced 4.71%	183,989 $3.2 Million
Q2 2020 Jul 28, 2020	BUY	$22.31 - $28.29 $587,957 - $745,554	26,354 Added 15.81%	193,081 $5.07 Million
Q1 2020 Apr 21, 2020	BUY	$17.75 - $27.72 $1.74 Million - $2.72 Million	98,240 Added 143.44%	166,727 $4.03 Million
Q4 2019 Feb 12, 2020	BUY	$21.0 - $24.83 $1.44 Million - $1.7 Million	68,487 New	68,487 $1.7 Million
Q4 2018 Feb 11, 2019	SELL	$31.18 - $44.64 $151,191 - $216,459	-4,849 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.3 - $53.5 $205,112 - $259,421	4,849 New	4,849 $208,000

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $440M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.